Reproductive factors and risk of hormone receptor positive and negative breast cancer: A cohort study

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Ritte, Rebecca ^a   Tikk, Kaja ^a   Lukanova, Annekatrin ^a   Tjønneland, Anne ^b   Olsen, Anja ^b   Overvad, Kim ^c   Dossus, Laure ^d,e   Fournier, Agnès ^d,e   Clavel Chapelon, Françoise ^d,e   Grote, Verena ^a   Boeing, Heiner ^f   Aleksandrova, Krasimira ^f   Trichopoulou, Antonia ^g,h   Lagiou, Pagona ^g,i,j   Trichopoulos, Dimitrios ^i,j   Palli, Domenico ^k   Berrino, Franco ^l   Mattiello, Amalia ^m   Tumino, Rosario ⁿ   Sacerdote, Carlotta ^o,p   Quirós, José R ^q   Buckland, Genevieve ^r   Molina Montes, Esther ^s,t   Chirlaque, María Dolores ^t,u   Ardanaz, Eva ^t,v   Amiano, Pilar ^t,w   Bueno de Mesquita, H B ^x,y   van Gils, Carla H ^y   Peeters, Petra H M ^y,z   Wareham, Nick ^aa   Khaw, Kay Tee ^ab   Key, Timothy J ^ac   Travis, Ruth C ^ae   Weiderpass, Elisabete ^ad,ae,af,ag   Dumeaux, Vanessa ^ad,ah   Lund, Eliv ^ad   Sund, Malin ^ai   Andersson, Anne ^aj   Romieu, Isabelle ^ak   Rinaldi, Sabina ^ak   Vineis, Paulo ^p,al   Merritt, Melissa A ^al   Riboli, Elio ^al   Kaaks, Rudolf ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^g UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^h HELLENIC HEALTH FOUNDATION   (Greece)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^k CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^l NATIONAL CANCER INSTITUTE   (Italy)

^m UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁿ CIVILE M P AREZZO HOSPITAL   (Italy)

^o Center for Cancer Prevention CPO Piemonte   (Italy)

^p HuGeF Foundation   (Italy)

^q Public Health and Health Planning Directorate   (Spain)

^r Unit of Nutrition Environment and Cancer   (Spain)

^s ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^t CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^u Murcia Regional Health Authority   (Spain)

^v INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^w BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^x NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^y UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^z IMPERIAL COLLEGE LONDON   (United Kingdom)

^aa MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^ab UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ac UNIVERSITY OF OXFORD   (United Kingdom)

^ad UNIVERSITY OF TROMSØ   (Norway)

^ae Cancer Registry of Norway ^*

^af KAROLINSKA INSTITUTE   (Sweden)

^ag FOLKHÄLSAN RESEARCH CENTER   (Finland)

^ah MCGILL UNIVERSITY   (Canada)

^ai UMEÅ UNIVERSITY   (Sweden)

^aj UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^ak INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^al IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Breast cancer; ER receptor; Menopause; Oral contraceptive; Parity; PR receptor; Reproductive factors; Risk factors

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ABORTION; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST FEEDING; CANCER RISK; CHILDBIRTH; COHORT ANALYSIS; DISEASE ASSOCIATION; ESTROGEN RECEPTOR NEGATIVE PROGESTERONE RECEPTOR NEGATIVE BREAST CANCER; ESTROGEN RECEPTOR POSITIVE PROGESTERONE RECEPTOR POSITIVE BREAST CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MENARCHE; MENOPAUSE; MIDDLE AGED; ORAL CONTRACEPTIVE USE; PARITY; PRIMIGRAVIDA; REPRODUCTION; RISK ASSESSMENT; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BREAST FEEDING; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; GRAVIDITY; HUMANS; MATERNAL AGE; MENARCHE; MENOPAUSE; MIDDLE AGED; PARITY; PREGNANCY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; YOUNG ADULT;

EID: 84889778927     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-584     Document Type: Article

References (42)

1. Weigelt B, Reis-Filho JS. Histological and molecular types of breast cancer: is there a unifying taxonomy?. Nat Rev Clin Oncol 2009, 6(12):718-730. 10.1038/nrclinonc.2009.166, 19942925.
2. Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 2004, 13(10):1558-1568.
3. Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006, 8(4):R43. 10.1186/bcr1525, 1779465, 16859501.
4. Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. J Clin Oncol 2007, 25(30):4772-4778. 10.1200/JCO.2007.12.2747, 17876012.
5. Geyer FC, Reis-Filho JS. Microarray-base gene expression profiling as a clinical tool for breast cancer management: Are we there yet?. Int J Surg Pathol 2008, 17(4):285-302.
6. Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schutz F, Goldstein DR, Piccart M, Delorenzi M. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 2008, 10(4):R65. 10.1186/bcr2124, 2575538, 18662380.
7. Perou CM, Sorlie T, Eisen MB, de RM V, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406(6797):747-752. 10.1038/35021093, 10963602.
8. Tamimi RM, Baer HJ, Marotti J, Galan M, Galaburda L, Fu Y, Deitz AC, Connolly JL, Schnitt SJ, Colditz GA, Collins LC. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res 2008, 10(4):R67. 10.1186/bcr2128, 2575540, 18681955.
9. Lord SJ, Bernstein L, Johnson KA, Malone KE, McDonald JA, Marchbanks PA, Simon MS, Strom BL, Press MF, Folger SG, Burkman RT, Deapen D, Spirtas R, Ursin G. Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev 2008, 17(7):1723-1730. 10.1158/1055-9965.EPI-07-2824, 2754711, 18628424.
10. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomaki K, Heikkila P, Blomqvist C, Lissowska J, Peplonska B, Chanock S, Figueroa J, Brinton L, Hall P, Czene K, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2011, 103(3):250-263. 10.1093/jnci/djq526, 3107570, 21191117.
11. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008, 109(1):123-139. 10.1007/s10549-007-9632-6, 2443103, 17578664.
12. Gierach GL, Burke A, Anderson WF. Epidemiology of triple negative breast cancers. Breast Dis 2010, 32(1-2):5-24.
13. Yasui Y, Potter JD. The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control 1999, 10(5):431-437. 10.1023/A:1008970121595, 10530614.
14. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 2011, 103(6):470-477. 10.1093/jnci/djr030, 3057984, 21346227.
15. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 2008, 113(7):1521-1526. 10.1002/cncr.23786, 2587413, 18726992.
16. Riboli E, Kaaks R. The EPIC project: rationale and study design. European Prospective Investigation into Cancer and nutrition. Int J Epidemiol 1997, 26(1):S6-S14.
17. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, Overvad K, Tjonneland A, Clavel-Chapelon F, Thiebaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-de-Mesquita HB, Peeters PH, Lund E, Engeset D, Gonzalez CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002, 5(6B):1113-1124. 10.1079/PHN2002394, 12639222.
18. Onland-Moret NC, Peeters PH, van Gils CH, Clavel-Chapelon F, Key T, Tjonneland A, Trichopoulou A, Kaaks R, Manjer J, Panico S, Palli D, Tehard B, Stoikidou M, Bueno-de-Mesquita HB, Boeing H, Overvad K, Lenner P, Quiros JR, Chirlaque MD, Miller AB, Khaw KT, Riboli E. Age at menarche in relation to adult height: the EPIC study. Am J Epidemiol 2005, 162(7):623-632. 10.1093/aje/kwi260, 16107566.
19. Haftenberger M, Lahmann PH, Panico S, Gonzalez CA, Seidell JC, Boeing H, Giurdanella MC, Krogh V, Bueno-de-Mesquita HB, Peeters PH, Skeie G, Hjartaker A, Rodriguez M, Quiros JR, Berglund G, Janlert U, Khaw KT, Spencer EA, Overvad K, Tjonneland A, Clavel-Chapelon F, Tehard B, Miller AB, Klipstein-Grobusch K, Benetou V, Kiriazi G, Riboli E, Slimani N. Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 2002, 5(6B):1147-1162. 10.1079/PHN2002396, 12639224.
20. James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjonneland A, Olsen A, Overvad K, Mesrine S, Engel P, Clavel-Chapelon F, Chang-Claude J, Vrieling A, Boeing H, Schutze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Krogh V, Panico S, Tumino R, Sacerdote C, Rodriguez L, Buckland G, Sanchez MJ, Amiano P, Ardanaz E, Bueno-de-Mesquita B, Ros MM, et al. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study. Cancer Prev Res 2011, 4(10):1626-1635.
21. Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, Hennings S, Day NE. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003, 6(4):407-413.
22. Heuch I, Albrektsen G, Kvale G. Modeling effects of age at and time since delivery on subsequent risk of cancer. Epidemiology 1999, 10(6):739-746. 10.1097/00001648-199911000-00015, 10535789.
23. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995, 51(2):524-532. 10.2307/2532940, 7662841.
24. Ritte R, Lukanova A, Berrino F, Dossus L, Tjonneland A, Olsen A, Overvad TF, Overvad K, Clavel-Chapelon F, Fournier A, Fagherazzi G, Rohrmann S, Teucher B, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Panico S, Tumino R, Vineis P, Quiros JR, Buckland G, Sanchez MJ, Amiano P, Chirlaque MD, Ardanaz E, Sund M, et al. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res 2012, 14(3):R76. 10.1186/bcr3186, 3446339, 22583394.
25. Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE. Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol 2009, 169(10):1251-1259. 10.1093/aje/kwp036, 2727208, 19318616.
26. Hankinson SE, Tamimi R, Hunter D. Breast cancer. Textbook of Cancer Epidemiology 2008, 403-445. Oxford: Oxford University Press, Adami H, Hunter D, Trichopoulos D, 2.
27. Ritte R, Lukanova A, Tjonneland A, Olsen A, Overvad K, Mesrine S, Fagherazzi G, Dossus L, Teucher B, Steindorf K, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Grioni S, Mattiello A, Tumino R, Sacerdote C, Quiros JR, Buckland G, Molina-Montes E, Chirlaque MD, Ardanaz E, Amiano P, Bueno-de-Mesquita B, Van DF, Van Gils CH, Peeters PH, et al. Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study. Int J Cancer J Int du cancer 2013, 132(11):2619-2629.
28. Apter D, Reinila M, Vihko R. Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 1989, 44(5):783-787. 10.1002/ijc.2910440506, 2511157.
29. Dietel M, Lewis MA, Shapiro S. Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review. Hum Reprod 2005, 20(8):2052-2060. 10.1093/humrep/dei043, 15932918.
30. Allred DC, Brown P, Medina D. The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer. Breast Cancer Res 2004, 6(6):240-245. 10.1186/bcr938, 1064085, 15535853.
31. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ, Visvader JE. Control of mammary stem cell function by steroid hormone signalling. Nature 2010, 465(7299):798-802. 10.1038/nature09027, 20383121.
32. Russo IH, Russo J. Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia 2011, 16(3):221-233. 10.1007/s10911-011-9228-y, 21805333.
33. Ma H, Bernstein L, Ross RK, Ursin G. Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res 2006, 8(4):R39. 10.1186/bcr1514, 1779482, 16846528.
34. Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, Malone KE. Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev 2009, 18(4):1157-1166. 10.1158/1055-9965.EPI-08-1005, 2754710, 19336554.
35. Althuis MD, Brogan DD, Coates RJ, Daling JR, Gammon MD, Malone KE, Schoenberg JB, Brinton LA. Breast cancers among very young premenopausal women (United States). Cancer Causes Control 2003, 14(2):151-160. 10.1023/A:1023006000760, 12749720.
36. Sweeney C, Giuliano AR, Baumgartner KB, Byers T, Herrick JS, Edwards SL, Slattery ML. Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women. Int J Cancer 2007, 121(11):2517-2523. 10.1002/ijc.22970, 17657739.
37. Rosenberg L, Boggs DA, Wise LA, Adams-Campbell LL, Palmer JR. Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women. Cancer Epidemiol Biomarkers Prev 2010, 19(8):2073-2079. 10.1158/1055-9965.EPI-10-0428, 2919607, 20647407.
38. Magne N, Toillon RA, Castadot P, Ramaioli A, Namer M. Different clinical impact of estradiol receptor determination according to the analytical method: a study on 1940 breast cancer patients over a period of 16 consecutive years. Breast Cancer Res Treat 2006, 95(2):179-184. 10.1007/s10549-005-9065-z, 16317583.
39. Chebil G, Bendahl PO, Idvall I, Ferno M. Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer-clinical associations and reasons for discrepancies. Acta Oncol 2003, 42(7):719-725. 10.1080/02841860310004724, 14690157.
40. Welsh AW, Moeder CB, Kumar S, Gershkovich P, Alarid ET, Harigopal M, Haffty BG, Rimm DL. Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells. J Clin Oncol 2011, 29(22):2978-2984. 10.1200/JCO.2010.32.9706, 3157961, 21709197.
41. Hede K. Breast cancer testing scandal shines spotlight on black box of clinical laboratory testing. J Natl Cancer Inst 2008, 100(12):836-837. 10.1093/jnci/djn200, 18544732.
42. Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 2001, 92(1):37-45. 10.1002/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F, 11443607.